Behavioural pharmacology of cannabinoids

被引：0
|
作者：
Bergman, J
Willner, P
Sanger, D
机构：
来源：
BEHAVIOURAL PHARMACOLOGY | 2005年 / 16卷 / 5-6期
关键词：
D O I：
10.1097/00008877-200509000-00001
中图分类号：
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号：
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要：
引用
收藏
页码：271 / 273
页数：3
相关论文
共 50 条
  • [1] Editorial: The Behavioural Pharmacology of Cannabinoids
    Vanderschuren, Louk
    Jutkiewicz, Emily
    Willner, Paul
    Ellenbroek, Bart
    BEHAVIOURAL PHARMACOLOGY, 2022, 33 (2-3): : 61 - 62
  • [2] Announcement of Special Issue: the behavioural pharmacology of cannabinoids
    Vanderschuren, Louk
    Willner, Paul
    Bergman, Jack
    Ellenbroek, Bart
    BEHAVIOURAL PHARMACOLOGY, 2020, 31 (2-3): : 112 - 112
  • [3] Pharmacology of cannabinoids
    Grotenhermen, F
    NEUROENDOCRINOLOGY LETTERS, 2004, 25 (1-2) : 14 - 23
  • [4] PHARMACOLOGY - ENDOGENOUS CANNABINOIDS
    IVERSEN, L
    NATURE, 1994, 372 (6507) : 619 - 619
  • [5] Pharmacology of cannabinoids in the treatment of epilepsy
    Gaston, Tyler E.
    Friedman, Daniel
    EPILEPSY & BEHAVIOR, 2017, 70 : 313 - 318
  • [6] Pharmacology and drug interactions of cannabinoids
    Landmark, Cecilie Johannessen
    Brandl, Ulrich
    EPILEPTIC DISORDERS, 2020, 22 : S16 - S22
  • [7] Behavioral pharmacology of cannabinoids in animals
    De Vry, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S129 - S129
  • [8] The gastrointestinal pharmacology of cannabinoids: an update
    Coutts, AA
    Izzo, AA
    CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (06) : 572 - 579
  • [9] The behavioural pharmacology of schizophrenia
    Sanger, D
    Young, A
    Willner, P
    BEHAVIOURAL PHARMACOLOGY, 2000, 11 (3-4): : 181 - 183
  • [10] The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility
    Abalo, Raquel
    Vera, Gema
    Lopez-Perez, Ana Esther
    Martinez-Villaluenga, Maria
    Martin-Fontelles, Maria Isabel
    PHARMACOLOGY, 2012, 90 (1-2) : 1 - 10
12345